---
title: Government Committee Greenlights First Ever Treatment for Peanut Allergies.
slug: 20190919-government-greenlights-first-ever-treatment-for-peanut-allergies
_id: legacy-48e86d04-63da-4eb2-9b27-b97612ecf269
_rev: f2cVhvAV1wntWw1uaAB5yS
type: quick_quotes
draft: false
aliases:
  - article/government-greenlights-first-ever-treatment-for-peanut-allergies/
_createdAt: '2019-09-18T16:12:36Z'
_updatedAt: '2021-03-22T13:12:18Z'
date: '2019-09-18T16:12:36+00:00'
lastmod: '2019-09-18T16:12:36+00:00'
weight: 50
is_breaking: false
featured_quote:
  quote: This is a big deal.

---
Pediatric allergist, Dr. BJ Lanser, at National Jewish Health, the hospital that helped run a clinical trial on a treatment for peanut allergy sufferers. He went on to say, This is a big deal, but with this caveat that this is not an easy, simple cure and the therapy isn”t going to be for everyone.

* **first-ever** peanut allergy treatment
* Patient receives doses orally.
* Initial patients: 4-17 years old.
* Works to de-sensitive patients to peanuts through giving them small doses.
* FDA Advisory Committee voted to approve the treatment – the FDA *normally* follows the committees recommendations for full approval to get the treatment to the U.S. market.

READ MORE:

[FDA committee votes to approve peanut allergy treatment that had clinical trials at National JewishA Health](https://kdvr.com/2019/09/16/fda-committee-votes-to-approve-peanut-allergy-treatment-that-had-clinical-trials-at-national-jewish-health/)